Nune Makarova

Eli Lilly (United States)1 paperOpenAlex

Papers

The New England Journal of MedicineHuman trial

Retatrutide reduces weight and pain in adults with obesity

Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.Mean body weight fell up to 25.0% with retatrutide versus 3.9% on placebo over 80 weeks in adults with obesity.